Van Hauwermeiren Timothy
SEC insider (Form 3/4/5 filer). CIK 0001816206. Director at Lexeo Therapeutics, Inc. (LXEO) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Van Hauwermeiren Timothy has filed insider reports for
- Lexeo Therapeutics, Inc. (LXEO): Director
- Denali Therapeutics Inc. (DNLI): Director
- iTeos Therapeutics, Inc. (ITOS): Director
Van Hauwermeiren Timothy
CIK: 0001816206
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirectStock Option (right to buy)
35K shares- - Jun 3, 2026DNLI
Denali Therapeutics Inc.
AwardDirect6.4K shares- - Nov 4, 2025DNLI
Denali Therapeutics Inc.
AwardDirect10.6K shares- - Jun 26, 2025LXEO
Lexeo Therapeutics, Inc.
AwardDirectStock Option (right to buy)
22.9K shares- - May 13, 2025ITOS
iTeos Therapeutics, Inc.
ExerciseDirect22.3K shares at avg. $4.30$96K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  LXEO Lexeo Therapeutics, Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jun 3, 2026 |  DNLI Denali Therapeutics Inc. | Award | 6,408 | - | $0 | Direct |
| Nov 4, 2025 | DNLI Denali Therapeutics Inc. | Award | 10,632 | - | - | Direct |
| Jun 26, 2025 | LXEO Lexeo Therapeutics, Inc. | Award Stock Option (right to buy) | 22,916 | - | - | Direct |
| May 13, 2025 |  ITOS iTeos Therapeutics, Inc. | Exercise | 22,346 | $4.30 | $96,088 | Direct |
1-5 of 5 transactions